Dual‐Targeted Nanoparticle‐in‐Microparticle System for Ulcerative Colitis Therapy
Advanced Healthcare Materials · 2023-12 · 12 (31)
DOI: 10.1002/adhm.202301518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 18.09.2023. Verfasst von Yawen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Medical College, 182 Tianmushan Rd, Hangzhou, 310013, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colitis, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Medical Science and Technology Project, Basic Scientific Research Project of Hangzhou Medical College.
Abstract (Originalsprache)
Conventional oral therapy for ulcerative colitis (UC) is associated with premature release or degradation of drugs in the harsh gastrointestinal environment, resulting in reduced therapeutic effectiveness. Consequently, the present study aims to develop a dual‐targeted delivery system with a nanoparticle‐in‐microparticle (nano‐in‐micro) structure. The prepared Asiatic Acid‐loaded delivery system (AA/CDM‐BT‐ALG) has pH‐sensitive properties. Cellular uptake evaluation confirms that nanoparticles exhibit targeted absorption by macrophages and Caco‐2 cells through mannose (Man) receptor and biotin‐mediated endocytosis, respectively. Therefore, this mechanism effectively enhances intracellular drug concentration. Additionally, the biodistribution study conducted on the gastrointestinal tract of mice indicates that the colon of the microspheres group shows higher fluorescence intensity with longer duration than the other groups. This finding indicates that the microspheres exhibit selective accumulation in areas of colon inflammation. In vivo experiments in colitis mice showed that AA/CDM‐BT‐ALG significantly alleviates the histopathological characteristics of the colon, reduced neutrophil, and macrophage infiltration, and decreases pro‐inflammatory cytokine expression. Furthermore, the effect of AA/CDM‐BT‐ALG on colitis is validated to be closely related to the TLR4/MyD88/NF‐κB signaling pathway. The present findings suggest that the development of a dual‐targeted delivery system is accomplished effectively, with the potential to serve as a drug‐controlled release system for treating UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Medical College, 182 Tianmushan Rd, Hangzhou, 310013, China.
- School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, 310013, China.
- School of Pharmacy, Wenzhou Medical University, Wenzhou, 325000, China.
ORCID-Profile: Yawen Zhang, Lina Yin
Förderung
- Natural Science Foundation of Zhejiang Province
- Zhejiang Medical Science and Technology Project
- Basic Scientific Research Project of Hangzhou Medical College
Zitieren
APA
Zhang, Y., Wu, Y., Yan, Y., Ma, Y., Tu, L., Shao, J., Tang, X., Chen, L., Liang, G., & Yin, L. (2023). Dual‐Targeted Nanoparticle‐in‐Microparticle System for Ulcerative Colitis Therapy. Advanced Healthcare Materials, 12(31). https://doi.org/10.1002/adhm.202301518
Vancouver
Zhang Y, Wu Y, Yan Y, Ma Y, Tu L, Shao J, et al. Dual‐Targeted Nanoparticle‐in‐Microparticle System for Ulcerative Colitis Therapy. Advanced Healthcare Materials. 2023;12(31). doi:10.1002/adhm.202301518
BibTeX
@article{Zhang2023,
author = {Zhang, Yawen and Wu, Yue and Yan, Yuping and Ma, Yijing and Tu, Linglan and Shao, Jingjing and Tang, Xuanyu and Chen, Lingfeng and Liang, Guang and Yin, Lina},
title = {Dual‐Targeted Nanoparticle‐in‐Microparticle System for Ulcerative Colitis Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {31},
doi = {10.1002/adhm.202301518}
}
EUVIMED